← Every applicant
Celltrion Inc FDA Approvals
6 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| AVTOZMANew drugJan 21, 2026INJECTABLE, IV (INFUSION) |
| EYDENZELTNew drugOct 2, 2025INJECTABLE, INJECTION |
| OMLYCLONew drugMar 7, 2025INJECTABLE, INJECTION |
| OSENVELTNew drugFeb 28, 2025INJECTABLE, INJECTION |
| AVTOZMANew drugJan 24, 2025INJECTABLE, INTRAVENOUS |
| STEQEYMANew drugDec 17, 2024INJECTABLE, SUBCUTANEOUS |